Last checked at 21 Sep 2021 07:00
Baillie Gifford Shin Nippon PLC (BGS) |
Legal Entity Identifier: X5XCIPCJQCSUF8H1FU83 Regulated Information Classification: Half Yearly Financial Report
| |
Results for the six months to 31 July 2021 | |
The Company's net asset value per share† fell by 1.3% compared to a 1.7% rise in the MSCI Japan Small Cap Index*. The share price decreased by 4.1%.
¾ High-end camping gear manufacturer Snow Peak was among the top contributors to performance over the past six months.
¾ Some of our longstanding internet businesses suffered a reversal in fortunes as their shares were sold off amidst a bout of profit taking. We remain confident in the long-term growth prospects of these businesses.
¾ Kamakura Shinsho was the only new stock purchased during this period. This is Japan's largest and only online portal offering a wide range of 'end-of-life' services.
¾ The dislocation caused by the pandemic across global equity markets, Japan included, is giving rise to some exceptional investment opportunities.
† After deducting borrowings at fair value.
* The Company's comparative index is the MSCI Japan Small Cap Index (total return and in sterling terms). See disclaimer at the end of this announcement.
Source: Refinitiv/Baillie Gifford and relevant underlying index providers. See disclaimer at end of this announcement.
Shin Nippon aims to achieve long term capital growth through investment principally in small Japanese companies which are believed to have above average prospects for growth. At 31 July 2021 the Company had total assets of £775.6 million (before deduction of bank loans of £59.6 million).
The Company is managed by Baillie Gifford, an Edinburgh based fund management group with approximately £353 billion under management and advice as at 20 September 2021.
Past performance is not a guide to future performance. The value of an investment and any income from it is not guaranteed and may go down as well as up and investors may not get back the amount invested. The Company has borrowed money to make further investments. This is commonly referred to as gearing. The risk is that, when this money is repaid by the Company, the value of these investments may not be enough to cover the borrowing and interest costs, and the Company makes a loss. If the Company's investments fall in value, gearing will increase the amount of this loss. The more highly geared the Company, the greater this effect will be.
Investment in investment trusts should be regarded as long term. You can find up to date performance information about Shin Nippon at shinnippon.co.uk.
20 September 2021
For further information please contact:
Alex Blake, Baillie Gifford & Co
Tel: 0131 275 2859
Mark Knight, Four Communications
Tel: 0203 697 4200 or 07803 758810
The following is the unaudited Interim Financial Report for the six months to 31 July 2021.
Responsibility Statement |
We confirm that to the best of our knowledge:
a) the condensed set of Financial Statements has been prepared in accordance with FRS 104 'Interim Financial Reporting';
b) the Interim Management Report includes a fair review of the information required by Disclosure and Transparency Rule 4.2.7R (indication of important events during the first six months, their impact on the Financial Statements and a description of the principal risks and uncertainties for the remaining six months of the year); and
c) the Interim Financial Report includes a fair review of the information required by Disclosure and Transparency Rule 4.2.8R (disclosure of related party transactions and changes therein).
On behalf of the Board
MN Donaldson
Chairman
20 September 2021
Interim Management Report |
In our most recent annual Manager's report, we noted the disruptive effects of the pandemic on the global economy. While the situation has moderated since then, thanks chiefly to ongoing vaccination programmes across most countries, a full-blown recovery feels some way off. Most developed economies have made meaningful progress with vaccination, but a number of emerging countries continue to face numerous challenges. Despite a painfully slow vaccine approval process, Japan has quickly caught up with most of its developed market peers in terms of vaccination rates. The high uptake of vaccines and falling hospitalisation rates in developed markets have encouraged governments to lift restrictions, resulting in a gradual return to normality for individuals and businesses. However, given the uneven nature of progress in vaccination across developed and emerging economies, investor sentiment has invariably remained one of caution.
Under these fluid and uncertain circumstances, the Japanese market remained subdued. For the six months to 31 July 2021, the MSCI Japan Small Cap index rose by 1.7% compared to a 1.3% fall in Shin Nippon's net asset value per share (after deducting borrowings at fair value). Over three and five years, which we believe is a fairer way of judging long-term investment performance, the comparative index has risen by 5.9% and 38.7% respectively, while the Company's net asset value per share has increased by 20.7% and 104.6%. We remain committed to our high-growth and long-term investment philosophy for Shin Nippon. The strong relative outperformance over longer periods of time illustrates the benefits of this approach. We continue to believe that for patient shareholders, Shin Nippon's style of high growth investing in Japanese smaller companies can be very rewarding in the long run.
High growth internet stocks were among the major beneficiaries of the pandemic last year. However, we have seen a reversal in investor sentiment over the past six months. Aggressive profit taking and a preference for cyclical companies has meant that numerous high growth small cap stocks have given up a lot of the share price gains made last year. Share price weakness notwithstanding, a number of the internet stocks held in Shin Nippon continue to deliver rapid growth despite a high base of comparison. Management teams at these companies remain committed to their long-term vision of dominating their chosen areas of operation and are investing accordingly, quite often at the expense of short-term profitability. Although the Japanese market takes a dim view of such an approach, we believe this mindset gives the best chance for entrepreneurs in Japan to succeed in the long-term.
Given our investment philosophy of seeking out and investing in immature, capital light, and rapid growth smaller businesses run by entrepreneurs, we have a natural bias towards online companies. However, over the past decade or so, we have witnessed a positive change in attitudes towards risk taking in Japan. This has given rise to numerous entrepreneurial smaller businesses across various sectors, deepening the pool of investible companies for Shin Nippon. Consequently, we have a well-diversified portfolio of rapid growth stocks operating in different industries. The composition of the top performing stocks over the past six months is a good illustration of this feature. High-end camping gear manufacturer, Snow Peak, was among the top contributors to performance over the period. Snow Peak has a strong reputation within Japan's camping community and has a dedicated and growing user-base. Camping as a recreational activity is seeing strong growth in Japan as an increasing number of 'second' baby boomers (those born in the early 1970s) and young families embrace this form of recreation. In the US, where the company is expanding aggressively, roughly one in three households now undertake camping, representing a large market for Snow Peak. The company is run by the founding family who own nearly 30%, thereby ensuring strong alignment.
Semiconductor equipment manufacturer, JEOL, was another strong performer. It makes high-powered microscopes and other scientific analysis equipment. It has also established a new business supplying specialised semiconductor manufacturing equipment that allows companies to shorten the time needed to develop semiconductor chips. JEOL is investing heavily in new capacity to meet the strong demand for this new product. Having suffered a deceleration in sales and profit growth due to the pandemic, manufacturing related staffing company, Outsourcing, has seen a sharp recovery this year. Production across its manufacturing clients is recovering strongly, resulting in a rapid recovery of demand for Outsourcing's staffing services.
Electronic components maker, Torex, also performed well. This is a niche manufacturer that specialises in designing low power devices. Having historically focused on consumer electronics, Torex is now finding applications for its products within autos and industrial electronics, and sales in both these areas are growing rapidly. More recently, the company has also been seeing strong demand for 5G and healthcare related applications. Another strong performer was WealthNavi, Japan's leading robo-advisory wealth management platform. It has built an easy-to-use online investing platform targeted at younger, middle-class families that currently have few options to invest for their future. A large part of these savings is currently in extremely low-yielding bank deposits and by offering a low-cost alternative, the company is seeking to gain a meaningful share of this sizeable pool of liquid assets. Since listing in December last year, WealthNavi's assets under management have continued to grow rapidly as its product offering gains traction within its target demographic.
As alluded to earlier, some of our longstanding internet businesses suffered a reversal in fortunes as their shares were sold off aggressively amidst a bout of profit taking. Japan's leading online food ordering and delivery platform, Demae-Can, continues to deliver rapid sales growth, but management are also investing heavily in expanding their delivery capabilities. This has resulted in large operating losses in the near term which the market has not taken kindly to. Similarly, aggressive forward-looking investment by the management of online real estate company, GA, Technologies has been punished by the market, resulting in considerable share price weakness.
One of Japan's leading digital contracts providers, Bengo4.com, was also among the poor performers. Having done very well last year, the shares have come under selling pressure amidst rising concerns around intensifying competition. Longstanding holding M3, Japan's largest online drug marketing platform, was also weak due to worries about a slowdown in future growth, following a strong tailwind from the pandemic last year. We remain confident in the long-term growth prospects of each of these businesses and remain supportive of management's efforts in trying to scale up their respective companies in order to secure long-term growth.
Portfolio activity remained relatively muted. Turnover for the six months to 31 July 2021 was 5.7%, which is in line with our long-term investment horizon. Active share remains high at 95% as we continue to pay less attention to the benchmark and instead, focus on each company's individual fundamental attractions while making an investment decision. Despite the very low turnover, we did make a few changes to the portfolio. Kamakura Shinsho was the only new stock purchased during this period. This is Japan's largest and only online portal offering a wide range of 'end-of-life' services. This is a large and traditional industry, with very little by way of IT usage. It is also quite an opaque, unregulated and poorly understood sector, resulting in the end consumer being charged exorbitant prices at a time of great vulnerability. Through its online model, Kamakura Shinsho is attempting to resolve these issues by offering customers a platform with complete price transparency and numerous options in terms of vendors. It is also gradually expanding the range of services it offers to include areas like inheritance and tax planning. We also sold two stocks during this period. Dream Incubator is a small consulting business that also has a venture capital arm. We had been shareholders in this company since 2013 but were disappointed with the lack of progress in terms of scaling the business and an absence of ambition and dynamism within the management team. Biotech company, Nanocarrier, was also sold from the portfolio as we lost conviction in management's ability to commercialise their proprietary drug-delivery platform following a series of failed trials.
Despite the disruption caused by the pandemic, we remain cautiously optimistic about a return to normality. Vaccination efforts across the globe are proceeding at a steady, albeit uneven, pace and in some countries, we are already seeing some normalisation in business conditions. The dislocation caused by the pandemic across global equity markets, Japan included, is giving rise to some exceptional investment opportunities for us. More encouragingly, the pandemic is also forcing through some very positive and much needed changes in business attitudes across Japan. Companies are being forced to adopt modern working practices, including the increased use of IT, and this is creating new growth opportunities for smaller companies in Japan. This combination of an expanding addressable market, a deepening pool of investible companies and attractive valuations gives us much cause for optimism and excitement at the prospect of unearthing and investing in such fast-growing smaller companies in Japan.
The principal risks and uncertainties facing the Company are set out following note 13 of this report.
Baillie Gifford & Co
20 September 2021
Past performance is not a guide to future performance
Income statement (unaudited) |
For the six months ended 31 July 2021 | For the six months ended 31 July 2020 | |||||
Revenue £'000 | Capital £'000 | Total £'000 | Revenue £'000 | Capital £'000 | Total £'000 | |
Net (losses)/gains on investments (note 3) | - | (14,428) | (14,428) | - | 27,068 | 27,068 |
Currency gains/(losses) | - | 3,442 | 3,442 | - | (1,008) | (1,008) |
Income from investments | 3,342 | - | 3,342 | 2,655 | - | 2,655 |
Investment management fee (note 4) | (2,124) | - | (2,124) | (1,490) | - | (1,490) |
Other administrative expenses | (306) | - | (306) | (261) | - | (261) |
Net return before finance costs and taxation | 912 | (10,986) | (10,074) | 904 | 26,060 | 26,964 |
Finance costs of borrowings | (456) | - | (456) | (572) | - | (572) |
Net return on ordinary activities before taxation | 456 | (10,986) | (10,530) | 332 | 26,060 | 26,392 |
Tax on ordinary activities (note 5) | (334) | - | (334) | (266) | - | (266) |
Net return on ordinary activities after taxation | 122 | (10,986) | (10,864) | 66 | 26,060 | 26,126 |
Net return per ordinary share (note 7) | 0.04p | (3.55p) | (3.51p) | 0.02p | 9.32p | 9.34p |
The total column of this statement is the profit and loss account of the Company. The supplementary revenue and capital columns are prepared under guidance published by the Association of Investment Companies.
All revenue and capital items in this statement derive from continuing operations.
A Statement of Comprehensive Income is not required as all gains and losses of the Company have been reflected in the above statement.
Balance sheet (unaudited) |
At 31 July 2021 | At 31 January 2021 (audited) | |
£'000 | £'000 | |
Fixed asset investments | ||
Investments held at fair value through profit or loss (note 8) | 766,182 | 750,943 |
Current assets | ||
Debtors | 5,195 | 2,158 |
Cash and cash equivalents | 5,519 | 10,438 |
| 10,714 | 12,596 |
Creditors | ||
Amounts falling due within one year (note 9) | (1,331) | (2,288) |
Net current assets | 9,383 | 10,308 |
Total assets less current liabilities | 775,565 | 761,251 |
Creditors | ||
Amounts falling due after more than one year (note 9) | (59,560) | (63,199) |
Total net assets | 716,005 | 698,052 |
Capital and reserves | ||
Share capital | 6,265 | 6,026 |
Share premium account | 257,727 | 229,149 |
Capital redemption reserve | 21,521 | 21,521 |
Capital reserve | 435,098 | 446,084 |
Revenue reserve | (4,606) | (4,728) |
Shareholders' funds | 716,005 | 698,052 |
Net asset value per ordinary share (after deducting borrowings at book value) |
228.6p |
231.7p |
Ordinary shares in issue (note 11) | 313,252,485 | 301,292,485 |
Statement of changes in equity (unaudited) |
For the six months ended 31 July 2021
Sharecapital £'000 | Sharepremium account £'000 | Capital redemption reserve £'000 | Capital reserve* £'000 | Revenue reserve £'000 | Shareholders' funds £'000 | |
Shareholders' funds at 1 February 2021 | 6,026 | 229,149 | 21,521 | 446,084 | (4,728) | 698,052 |
Ordinary shares issued | 239 | 28,578 | - | - | - | 28,817 |
Net return on ordinary activities after taxation | - | - | - | (10,986) | 122 | (10,864) |
Shareholders' funds at 31 July 2021 | 6,265 | 257,727 | 21,521 | 435,098 | (4,606) | 716,005 |
For the six months ended 31 July 2020
Sharecapital £'000 | Sharepremium account £'000 | Capital redemption reserve £'000 | Capital reserve* £'000 | Revenue reserve £'000 | Shareholders' funds £'000 | |
Shareholders' funds at 1 February 2020 | 5,591 | 174,208 | 21,521 | 286,983 | (4,587) | 483,716 |
Net return on ordinary activities after taxation | - | - | - | 26,060 | 66 | 26,126 |
Shareholders' funds at 31 July 2020 | 5,591 | 174,208 | 21,521 | 313,043 | (4,521) | 509,842 |
* The Capital reserve includes investment holding gains of £238,572,000 (31 July 2020 - gains of £155,794,000).
Condensed Cash Flow Statement (unaudited) |
Six months to 31 July 2021 | Six months to 31 July 2020 | |
£'000 | £'000 | |
Cash flows from operating activities | ||
Net return on ordinary activities before taxation | (10,530) | 26,392 |
Net losses/(gains) on investments | 14,428 | (27,068) |
Currency (gains)/losses | (3,442) | 1,008 |
Finance costs of borrowings | 456 | 572 |
Overseas withholding tax | (356) | (344) |
Changes in debtors and creditors | 311 | 820 |
Cash from operations | 867 | 1,380 |
Interest paid | (451) | (553) |
Net cash inflow from operating activities | 416 | 827 |
Net cash (outflow)/inflow from investing activities | (34,553) | 6,961 |
Ordinary shares issued | 29,431 | - |
Net cash inflow from financing activities | 29,431 | - |
(Decrease)/increase in cash and cash equivalents | (4,706) | 7,788 |
Exchange movements | (213) | 533 |
Cash and cash equivalents at start of period | 10,438 | 5,736 |
Cash and cash equivalents at end of period * | 5,519 | 14,057 |
* Cash and cash equivalents represent cash at bank and short term money market deposits repayable on demand.
Twenty largest equity holdings at 31 July 2021 |
Name |
Business | Value £'000 | % of total assets | Absolute performance * % |
JEOL | Manufacturer of scientific equipment | 26,396 | 3.4 | 56.8 |
Outsourcing | Employment placement services | 26,217 | 3.4 | 49.3 |
Raksul | Internet based services | 24,810 | 3.2 | 16.1 |
Snow Peak | Designs & manufactures outdoor lifestyle goods | 20,241 | 2.6 | 114.6 |
WealthNavi | Digital robo wealth-management | 19,648 | 2.5 | 59.0 |
Tsugami | Manufacturer of automated machine tools | 18,819 | 2.4 | (14.6) |
GMO Payment Gateway | Online payment processing | 18,106 | 2.3 | (11.4) |
Shoei | Manufactures motorcycle helmets | 17,990 | 2.3 | 0.9 |
Litalico | Provides employment support and learning support services for people with disabilities |
16,917 |
2.2 |
36.2 |
Kitanotatsujin | Online retailer | 16,620 | 2.1 | (10.7) |
Katitas | Real estate services | 16,046 | 2.1 | (1.6) |
Nihon M&A Center | M&A advisory services | 15,858 | 2.0 | (5.5) |
Descente | Manufactures athletic clothing | 15,661 | 2.0 | 65.5 |
Megachips | Electronic components | 15,626 | 2.0 | - |
Bengo4.com | Online legal consultation | 15,584 | 2.0 | (33.5) |
Torex Semiconductor | Semiconductor company | 15,283 | 2.0 | 91.3 |
Horiba | Manufacturer of measuring instruments | 14,942 | 1.9 | 3.6 |
Infomart | Internet platform for restaurant supplies | 14,901 | 1.9 | (5.4) |
M3 | Online medical services | 14,747 | 1.9 | (23.6) |
MonotaRO | Online business supplies | 14,396 | 1.9 | (9.5) |
358,808 | 46.1 |
* Absolute performance is in sterling terms and has been calculated on a total return basis over the period 1 February 2021 to 31 July 2021.
Source: Baillie Gifford/StatPro and relevant underlying data providers.
Past performance is not a guide to future performance.
Notes to the condensed financial statements (unaudited) |
1. | The condensed Financial Statements for the six months to 31 July 2021 comprise the statements set out on the previous pages together with the related notes below. They have been prepared in accordance with FRS 104 'Interim Financial Reporting' and the principles of the AIC's Statement of Recommended Practice issued in November 2014 and updated in April 2021 with consequential amendments and have not been audited or reviewed by the Auditor pursuant to the Auditing Practices Board Guidance on 'Review of Interim Financial Information'. The Financial Statements for the six months to 31 July 2021 have been prepared on the basis of the same accounting policies as set out in the Company's Annual Report and Financial Statements at 31 January 2021.
Going Concern The Directors have considered the nature of the Company's principal risks and uncertainties, as set out below, together with its current position, investment objective and policy, its assets and liabilities and projected income and expenditure. The Board has, in particular, considered the impact of heightened market volatility since the Covid-19 outbreak and reviewed the results of specific leverage and liquidity stress testing but does not believe the Company's going concern status is affected. The Company's assets, which are primarily investments in quoted securities which are readily realisable (Level 1), exceed its liabilities significantly and could be sold to repay borrowings if required. All borrowings require the prior approval of the Board. Gearing levels and compliance with loan covenants are reviewed by the Board on a regular basis. The Company has continued to comply with the investment trust status requirements of section 1158 of the Corporation Tax Act 2010 and the Investment Trust (Approved Company) Regulations 2011. Accordingly, the Directors considered it appropriate to adopt the going concern basis of accounting in preparing these Financial Statements and confirm that they are not aware of any material uncertainties which may affect the Company's ability to continue in operational existence for a period of at least twelve months from the date of approval of these Financial Statements. | |||
2. | The financial information contained within this Interim Financial Report does not constitute statutory accounts as defined in sections 434 to 436 of the Companies Act 2006. The financial information for the year ended 31 January 2021 has been extracted from the statutory accounts which have been filed with the Registrar of Companies. The Auditor's Report on these accounts was not qualified, did not include a reference to any matters to which the Auditor drew attention by way of emphasis without qualifying their report, and did not contain a statement under sections 498 (2) or (3) of the Companies Act 2006. | |||
3. | Six months to 31 July 2021 | Six months to 31 July 2020 | ||
£'000 | £'000 | |||
Net gains on investments |
|
|
| |
Gains on sales of investments |
| 6,841 | 22,148 | |
Movement in investment holdings gains |
| (21,269) | 4,920 | |
(14,428) | 27,068 | |||
4. | Baillie Gifford & Co Limited, a wholly owned subsidiary of Baillie Gifford & Co, has been appointed by the Company as its Alternative Investment Fund Manager (AIFM) and Company Secretary. The investment management function has been delegated to Baillie Gifford & Co. The management agreement can be terminated on six months' notice. The annual management fee is 0.75% on the first £50m of net assets, 0.65% on the next £200m of net assets and 0.55% on the remainder, calculated and payable quarterly. | |||
5. | The Company suffers overseas withholding tax on its equity income, currently at the rate of 10%. | |||
6. | No interim dividend will be declared. | |||
Notes to the condensed financial statements (unaudited) (ctd) |
7. | Six months to 31 July 2021 | Six months to 31 July 2020 | ||||||
£'000 | £'000 | |||||||
Net return per ordinary share |
|
|
| |||||
Revenue return |
| 122 | 66 | |||||
Capital return |
| (10,986) | 26,060 | |||||
Total return | (10,864) | 26,126 | ||||||
Net return per ordinary share is based on the above totals of revenue and capital and on 309,882,900 (31 July 2020 - 279,577,485) ordinary shares, being the weighted average number of ordinary shares in issue during the period. There are no dilutive or potentially dilutive shares in issue. | ||||||||
8. | Fair Value The fair value hierarchy used to analyse the basis on which the fair values of financial instruments held at fair value through the profit or loss account are measured is described below. Fair value measurements are categorised on the basis of the lowest level input that is significant to the fair value measurement. Level 1 - using unadjusted quoted prices for identical instruments in an active market; Level 2 - using inputs, other than quoted prices included within Level 1, that are directly or indirectly observable (based on market data); and Level 3 - using inputs that are unobservable (for which market data is unavailable). The Company's investments are financial assets held at fair value through profit or loss. An analysis of the Company's financial asset investments based on the fair value hierarchy described above is shown below: | |||||||
|
| |||||||
| As at 31 July 2021 | Level 1 £'000 | Level 2 £'000 | Level 3 £'000 | Total £'000 | |||
| Listed equities | 756,135 | - | - | 756,135 | |||
| Private company securities | - | - | 10,047 | 10,047 | |||
| Total financial asset investments | 756,135 | - | 10,047 | 766,182 | |||
|
|
|
|
|
| |||
| As at 31 January 2021 | Level 1 £'000 | Level 2 £'000 | Level 3 £'000 | Total £'000 | |||
| Listed equities | 741,185 | - | - | 741,185 | |||
| Private company securities | - | - | 9,758 | 9,758 | |||
| Total financial asset investments | 741,185 | - | 9,758 | 750,943 | |||
Notes to the condensed financial statements (unaudited) (ctd) |
8. (ctd) | There have been no transfers between levels of the fair value hierarchy during the period. The fair value of listed investments is last traded price which is equivalent to the bid price on Japanese markets. Listed investments are categorised as Level 1 if they are valued using unadjusted quoted prices for identical instruments in an active market and as Level 2 if they do not meet all these criteria but are, nonetheless, valued using market data. Private company investments are valued at fair value by the Directors following a detailed review and appropriate challenge of the valuations proposed by the Managers. The Managers' private company valuation policy applies methodologies consistent with the International Private Equity and Venture Capital Valuation guidelines 2018 ('IPEV'). The techniques applied are predominantly market-based approaches. The market-based approaches available under IPEV are set out below: - Multiples; - Industry Valuation Benchmarks; and - Available Market Prices. The Company's holdings in private company investments are categorised as Level 3 as unobservable data is a significant input to their fair value measurements. |
9. | There are no bank loans falling due within one year (31 January 2021 - nil). The amounts falling due after more than one year include bank loans of £59,560,000 (¥9.10 billion) outstanding under yen loan facilities repayable on 27 November 2023 and 18 December 2024 (31 January 2021 - £63,199,000 (¥9.10 billion)). |
10. | The fair value of the bank loans at 31 July 2021 was £60,207,000 (31 January 2021 - £63,740,000). |
11. | The Company has the authority to issue shares/sell treasury shares at a premium to net asset value as well as to buy back shares at a discount to net asset value. During the period under review, 11,960,000 shares were issued raising net proceeds of £28,817,000 (31 July 2020 - nil). No shares were bought back during the period under review (31 July 2020 - nil). |
12. | Transaction costs incurred on the purchase and sale of the investments are added to the purchase cost or deducted from the sale proceeds, as appropriate. During the period, transaction costs on purchases amounted to £23,000 (31 July 2020 - £26,000) and transaction costs on sales amounted to £9,000 (31 July 2020 - £34,000). |
13. | Related party transactions There have been no transactions with related parties during the first six months of the current financial year that have materially affected the financial position or the performance of the Company during that period and there have been no changes in the related party transactions described in the last Annual Report and Financial Statements that could have had such an effect on the Company during that period. |
None of the views expressed in this document should be construed as advice to buy or sell a particular investment. | |
Principal Risks and Uncertainties The principal risks facing the Company are financial risk, investment strategy risk, discount risk, regulatory risk, custody and depositary risk, small company risk, operational risk, leverage risk and political risk. An explanation of these risks and how they are managed is set out on pages 8 and 9 of the Company's Annual Report and Financial Statements for the year to 31 January 2021 which is available on the Company's website: shinnippon.co.uk. The principal risks and uncertainties have not changed since the date of that report. | |
The Interim Financial Report will be available on shinnippon.co.uk‡ and will be posted to shareholders on or around 1 October 2021.
‡ Neither the contents of the Managers' website nor the contents of any website accessible from hyperlinks on the Managers' website (or any other website) is incorporated into, or forms part of, this announcement.
Glossary of Terms and Alternative Performance Measures (APM)
An alternative performance measure is a financial measure of historical or future financial performance, financial position, or cash flows, other than a financial measure defined or specified in the applicable financial reporting framework. The APMs noted below are commonly used measures within the investment trust industry and serve to improve comparability between investment trusts.
Total Assets
Total assets less current liabilities, before deduction of all borrowings.
Net Asset Value
Also described as shareholders' funds, Net Asset Value (NAV) is the value of total assets less liabilities (including borrowings). The NAV per share is calculated by dividing this amount by the number of ordinary shares in issue.
Net Asset Value (Borrowings at Book Value)
Borrowings are valued at adjusted net issue proceeds. The Company's yen denominated loans are valued at their sterling equivalent and adjusted for their arrangement fees. The value of the borrowings on this basis is set out in note 9 above.
Net Asset Value (Borrowings at Fair Value) (APM)
This is a widely reported measure across the investment trust industry. Borrowings are valued at an estimate of their market worth. The Company's yen denominated loans are fair valued using methodologies consistent with International Private Equity and Venture Capital Valuation ('IPEV') guidelines. The value of the borrowings on this basis is set out in note 10 above.
31 July 2021 | 31 January 2021 | |
Net Asset Value per ordinary share (borrowings at book value) | 228.6p | 231.7p |
Shareholders' funds (borrowings at book value) | £716,005,000 | £698,052,000 |
Add: book value of borrowings | £59,560,000 | £63,199,000 |
Less: fair value of borrowings | (£60,207,000) | (£63,740,000) |
Shareholders' funds (borrowings at fair value) | £715,358,000 | £697,511,000 |
Shares in issue at period end | 313,252,485 | 301,292,485 |
Net Asset Value per ordinary share (borrowings at fair value) | 228.4p | 231.5p |
Net Liquid Assets
Net liquid assets comprise current assets less current liabilities, excluding borrowings.
Discount/Premium (APM)
As stockmarkets and share prices vary, an investment trust's share price is rarely the same as its NAV. When the share price is lower than the NAV per share it is said to be trading at a discount. The size of the discount is calculated by subtracting the share price from the NAV per share and is usually expressed as a percentage of the NAV per share. If the share price is higher than the NAV per share, this situation is called a premium.
31 July 2021 NAV (book) | 31 July 2021 NAV (fair) | 31 January 2021 NAV (book) | 31 January 2021 NAV (fair) | |
Closing NAV per share | 228.6p | 228.4p | 231.7p | 231.5p |
Closing Share Price | 234.0p | 234.0p | 244.0p | 244.0p |
Premium | 2.4% | 2.5% | 5.3% | 5.4% |
Total Return (APM)
The total return is the return to shareholders after reinvesting the net dividend on the date that the share price goes ex-dividend. The Company does not pay a dividend.
Ongoing Charges (APM)
The total expenses (excluding borrowing costs) incurred by the Company as a percentage of the average net asset value (with debt at fair value). The ongoing charges have been calculated on the basis prescribed by the Association of Investment Companies.
Gearing (APM)
At its simplest, gearing is borrowing. Just like any other public company, an investment trust can borrow money to invest in additional investments for its portfolio. The effect of the borrowing on the shareholders' assets is called 'gearing'. If the Company's assets grow, the shareholders' assets grow proportionately more because the debt remains the same. But if the value of the Company's assets falls, the situation is reversed. Gearing can therefore enhance performance in rising markets but can adversely impact performance in falling markets.
Gearing represents borrowings at book less cash and cash equivalents expressed as a percentage of shareholders' funds.
Potential gearing is the Company's borrowings expressed as a percentage of shareholders' funds.
Equity gearing is the Company's borrowings adjusted for cash, expressed as a percentage of shareholders' funds.
Leverage (APM)
For the purposes of the Alternative Investment Fund Managers (AIFM) Directive, leverage is any method which increases the Company's exposure, including the borrowing of cash and the use of derivatives. It is expressed as a ratio between the Company's exposure and its net asset value and can be calculated on a gross and a commitment method. Under the gross method, exposure represents the sum of the Company's positions after the deduction of sterling cash balances, without taking into account any hedging and netting arrangements. Under the commitment method, exposure is calculated without the deduction of sterling cash balances and after certain hedging and netting positions are offset against each other.
Active Share (APM)
Active share, a measure of how actively a portfolio is managed, is the percentage of the portfolio that differs from its comparative index. It is calculated by deducting from 100 the percentage of the portfolio that overlaps with the comparative index. An active share of 100 indicates no overlap with the index and an active share of zero indicates a portfolio that tracks the index.
Third party data providers disclaimer
No third party data provider ('Provider') makes any warranty, express or implied, as to the accuracy, completeness or timeliness of the data contained herewith nor as to the results to be obtained by recipients of the data. No Provider shall in any way be liable to any recipient of the data for any inaccuracies, errors or omissions in the index data included in this document, regardless of cause, or for any damages (whether direct or indirect) resulting therefrom.
No Provider has any obligation to update, modify or amend the data or to otherwise notify a recipient thereof in the event that any matter stated herein changes or subsequently becomes inaccurate.
Without limiting the foregoing, no Provider shall have any liability whatsoever to you, whether in contract (including under an indemnity), in tort (including negligence), under a warranty, under statute or otherwise, in respect of any loss or damage suffered by you as a result of or in connection with any opinions, recommendations, forecasts, judgements, or any other conclusions, or any course of action determined, by you or any third party, whether or not based on the content, information or materials contained herein.
MSCI Index Data
MSCI makes no express or implied warranties or representations and shall have no liability whatsoever with respect to any MSCI data contained herein. The MSCI data may not be further redistributed or used as a basis for other indexes or any securities or financial products. This document is not approved, endorsed, reviewed or produced by MSCI. None of the MSCI data is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such.
-Ends-